Pneumococcal Titer Levels: Comparison Of Patients Receiving Intravenous Immunoglobulin Vs. Subcutaneous Immunoglobulin

被引:2
|
作者
Abghari, Pamella [1 ,2 ]
Secord, Elizabeth A. [1 ,2 ]
Poowuttikul, Pavadee [1 ,3 ]
机构
[1] Childrens Hosp Michigan, Dept Allergy Immunol, Detroit, MI 48201 USA
[2] Wayne State Univ, Detroit, MI USA
[3] Wayne State Univ, Sch Med, Pediat Allergy Immunol Div, Detroit, MI USA
关键词
D O I
10.1016/j.jaci.2013.12.061
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
37
引用
收藏
页码:AB10 / AB10
页数:1
相关论文
共 50 条
  • [21] Successful desensitization with subcutaneous immunoglobulin after recurrent anaphylaxis to intravenous immunoglobulin
    Boursiquot, Jean-Nicolas
    Shuster, Joseph
    Soukos, Christos
    CLINICAL IMMUNOLOGY, 2008, 127 : S67 - S67
  • [22] Subcutaneous Immunoglobulin Overcome Intravenous Immunoglobulin Limitation in Protein Losing Enteropathy
    Trizzino, A.
    Trizzino, A.
    Mosa, C.
    Macaluso, A.
    Valore, L.
    D'Angelo, P.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S306 - S307
  • [23] The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
    Chapel, HM
    Spickett, GP
    Ericson, D
    Engl, W
    Eibl, MM
    Bjorkander, J
    JOURNAL OF CLINICAL IMMUNOLOGY, 2000, 20 (02) : 94 - 100
  • [24] The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
    Björkander, J
    Spickett, G
    Ericson, D
    Engl, W
    Eibl, M
    Chapel, H
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S174 - S175
  • [25] The Comparison of the Efficacy and Safety of Intravenous Versus Subcutaneous Immunoglobulin Replacement Therapy
    H. M. Chapel
    G. P. Spickett
    D. Ericson
    W. Engl
    M. M. Eibl
    J. Bjorkander
    Journal of Clinical Immunology, 2000, 20 : 94 - 100
  • [26] ANTI-HIV ANTIBODIES IN PATIENTS RECEIVING INTRAVENOUS IMMUNOGLOBULIN
    BLOOM, RD
    TRIGLIA, D
    ASSER, S
    ANNALS OF ALLERGY, 1988, 61 (01): : 30 - 34
  • [27] ANTI-HIV ANTIBODY IN PATIENTS RECEIVING INTRAVENOUS IMMUNOGLOBULIN
    BLOOM, R
    JENSEN, F
    ASSER, S
    ANNALS OF ALLERGY, 1987, 58 (04): : 300 - 300
  • [28] Hepatitis B screening in hematology patients receiving intravenous immunoglobulin
    Liston, K.
    Prior, A. R.
    McHugh, J.
    Enright, H.
    Desmond, R.
    TRANSFUSION, 2024, 64 (09) : 1612 - 1615
  • [29] Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
    Scheuerlein, Philipp
    Pietsch, Larissa
    Camacho-Ordonez, Nadezhda
    Reiser, Veronika
    Patel, Smita
    Burns, Siobhan O.
    Warnatz, Klaus
    Grimbacher, Bodo
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [30] Subcutaneous immunoglobulin replacement (SCIG) for IgA-deficient patients unable to tolerate intravenous immunoglobulin (IVIG)
    Thompson, A.
    Brooks, J.
    Lobo, F.
    ALLERGY AND ASTHMA PROCEEDINGS, 2017, 38 (04) : 329 - 329